André Mouraux - Principal investigator (IONS/COSY)
Group :

Using non-invasive functional neuroimaging techniques such as electroencephalography (EEG) and functional magnetic resonance imaging (fMRI), combined with novel techniques to selectively activate specific classes of nociceptive afferents, the research performed by the team of André Mouraux (IONS/COSY) follows two main axes. First, to understand how the human brain processes nociceptive sensory input and how this leads to the perception of pain. Second, to understand the plastic changes in nociceptive pathways that occur after inflammation, injury or sustained nociceptive input that induce peripheral and central sensitization and may underlie the development of chronic pain in humans.



Publications
2023
Comparison between pupillometry and numeric pain rating scale for pain assessments in communicating adult patients in the emergency department
Eur J Pain
Gregoire C, Charier D, de Bergeyck R, Mouraux A, Van Ouytsel F, Lambert R, Zhou N, Lavand'homme P, Penaloza A, Pickering G.
in press.
2023
Pain-free default mode network connectivity contributes to tonic experimental pain intensity beyond the role of negative mood and other pain-related factors
Eur J Pain
Alhajri N, Boudreau SA, Mouraux A, Graven-Nielsen T.
in press.
2023
Neural evidence for functional roles of tactile and visual feedback in the application of myoelectric prosthesis
J Neural Eng
Su S, Chai G, Xu W, Meng J, Sheng X, Mouraux A, Zhu X.
20(1).
2022
High-speed heating of the skin using a contact thermode elicits comparable brain responses to those elicited by a CO2-laser device
Clin Neurophysiol
Lejeune N, Petrossova E, Frahm KS, Mouraux A.
146:1-9.
2022
Characterization of vagus nerve stimulation-induced pupillary responses in epileptic patients
Brain Stimulation
Vespa S, Stumpp L, Liberati G, Delbeke J, Nonclercq A, Mouraux A, El Tahry R
in press.
2022
Chronic temporomandibular disorders are associated with higher susceptibility to developing central sensitization: a case-control study
Pain
Cayrol T, van den Broeke EN, Gerard E, Meeus M, Mouraux A, Roussel N, Pitance L.
in press.
2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity
Trials
Leone C, Di Stefano G, Di Pietro G, Bloms-Funke P, Boesl I, Caspani O, Chapman SC, Finnerup NB, Garcia-Larrea L, Li T, Goetz M, Mouraux A, Pelz B, Pogatzki-Zahn E, Schilder A, Schnetter E, Schubart K, Tracey I, Troconiz IF, Van Niel H, Hernandez JMV, Vincent K, Vollert J, Wanigasekera V, Wittayer M, Phillips KG, Truini A, Treede RD.
23(1):739.